| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycoproteins | 19 | 2022 | 370 | 4.390 |
Why?
|
| Kidney | 28 | 2023 | 1367 | 2.730 |
Why?
|
| Acute Kidney Injury | 9 | 2024 | 635 | 1.620 |
Why?
|
| Nephritis, Interstitial | 2 | 2023 | 38 | 1.580 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 3 | 2024 | 14 | 1.410 |
Why?
|
| Mitochondria | 7 | 2022 | 684 | 1.410 |
Why?
|
| Superoxides | 8 | 2021 | 152 | 1.170 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 728 | 0.990 |
Why?
|
| Ion Channels | 7 | 2014 | 191 | 0.980 |
Why?
|
| Ischemic Preconditioning | 2 | 2015 | 19 | 0.980 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 115 | 0.970 |
Why?
|
| Hypertonic Solutions | 7 | 2006 | 20 | 0.960 |
Why?
|
| Mitochondrial Proteins | 6 | 2014 | 228 | 0.930 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 207 | 0.850 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 39 | 0.770 |
Why?
|
| Cisplatin | 4 | 2019 | 249 | 0.740 |
Why?
|
| Gluconeogenesis | 1 | 2021 | 106 | 0.720 |
Why?
|
| Signal Transduction | 10 | 2019 | 4537 | 0.710 |
Why?
|
| Lactic Acid | 1 | 2021 | 153 | 0.690 |
Why?
|
| Animals | 50 | 2024 | 34248 | 0.690 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 238 | 0.670 |
Why?
|
| Glomerular Mesangium | 3 | 2021 | 19 | 0.660 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2020 | 1117 | 0.620 |
Why?
|
| Antioxidants | 2 | 2012 | 369 | 0.590 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 48 | 0.590 |
Why?
|
| Mice | 24 | 2024 | 17646 | 0.580 |
Why?
|
| Ureteral Obstruction | 6 | 2004 | 105 | 0.570 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 2398 | 0.560 |
Why?
|
| Membrane Glycoproteins | 5 | 2009 | 411 | 0.540 |
Why?
|
| Cell Line | 14 | 2024 | 2757 | 0.540 |
Why?
|
| Macrophages | 4 | 2012 | 620 | 0.530 |
Why?
|
| Transforming Growth Factor beta | 4 | 2018 | 459 | 0.530 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 213 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 14 | 2022 | 4408 | 0.520 |
Why?
|
| Apoptosis | 10 | 2024 | 1803 | 0.520 |
Why?
|
| Nephritis | 1 | 2015 | 20 | 0.490 |
Why?
|
| Angiotensin II | 4 | 2012 | 165 | 0.490 |
Why?
|
| Thrombin | 1 | 2015 | 60 | 0.490 |
Why?
|
| Sirtuin 3 | 3 | 2021 | 9 | 0.450 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 37 | 0.450 |
Why?
|
| Kidney Tubules | 6 | 2020 | 77 | 0.440 |
Why?
|
| Lung Injury | 1 | 2015 | 122 | 0.440 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2022 | 130 | 0.440 |
Why?
|
| Postoperative Complications | 3 | 2020 | 3069 | 0.440 |
Why?
|
| Smad3 Protein | 1 | 2013 | 55 | 0.420 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 243 | 0.420 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 96 | 0.420 |
Why?
|
| Agrochemicals | 2 | 2023 | 13 | 0.420 |
Why?
|
| Myocytes, Cardiac | 2 | 2012 | 638 | 0.420 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 2523 | 0.410 |
Why?
|
| Cytoprotection | 2 | 2010 | 38 | 0.410 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 162 | 0.410 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 2 | 2009 | 8 | 0.400 |
Why?
|
| RNA, Messenger | 15 | 2017 | 2821 | 0.400 |
Why?
|
| Fibrosis | 3 | 2013 | 435 | 0.400 |
Why?
|
| Receptors, Ghrelin | 3 | 2018 | 28 | 0.400 |
Why?
|
| Up-Regulation | 6 | 2019 | 867 | 0.390 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 209 | 0.390 |
Why?
|
| Collagen | 1 | 2013 | 318 | 0.390 |
Why?
|
| Kidney Diseases | 2 | 2010 | 480 | 0.380 |
Why?
|
| Glomerulonephritis, IGA | 2 | 2021 | 16 | 0.360 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 429 | 0.360 |
Why?
|
| Hormones | 2 | 2003 | 186 | 0.350 |
Why?
|
| Reactive Oxygen Species | 6 | 2021 | 499 | 0.330 |
Why?
|
| Male | 34 | 2023 | 61388 | 0.320 |
Why?
|
| Endothelium | 1 | 2009 | 70 | 0.320 |
Why?
|
| Integrin beta1 | 2 | 2000 | 56 | 0.310 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 114 | 0.310 |
Why?
|
| Water-Electrolyte Balance | 3 | 2004 | 82 | 0.310 |
Why?
|
| Renal Dialysis | 5 | 2019 | 854 | 0.300 |
Why?
|
| Paraquat | 2 | 2022 | 13 | 0.300 |
Why?
|
| Rats | 13 | 2022 | 3729 | 0.300 |
Why?
|
| Dogs | 8 | 2006 | 774 | 0.300 |
Why?
|
| Uncoupling Protein 2 | 3 | 2014 | 13 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 293 | 0.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 118 | 0.290 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 412 | 0.290 |
Why?
|
| HEK293 Cells | 2 | 2022 | 737 | 0.290 |
Why?
|
| Cell Nucleus | 2 | 2008 | 680 | 0.280 |
Why?
|
| Uncompensated Care | 1 | 2007 | 10 | 0.280 |
Why?
|
| Catheters, Indwelling | 2 | 1998 | 154 | 0.280 |
Why?
|
| Cytoplasm | 1 | 2008 | 295 | 0.280 |
Why?
|
| Humans | 40 | 2023 | 124936 | 0.270 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 80 | 0.270 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2006 | 9 | 0.260 |
Why?
|
| Antigens, CD | 2 | 2000 | 432 | 0.260 |
Why?
|
| Contrast Media | 1 | 2010 | 479 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 1243 | 0.250 |
Why?
|
| Aging | 3 | 2018 | 1183 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 4 | 2019 | 880 | 0.240 |
Why?
|
| Calcium | 4 | 2006 | 1101 | 0.240 |
Why?
|
| Hydrogen Peroxide | 2 | 2015 | 112 | 0.230 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 115 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2007 | 371 | 0.220 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2004 | 61 | 0.220 |
Why?
|
| Tetrazoles | 1 | 2004 | 69 | 0.220 |
Why?
|
| Acetylcysteine | 2 | 2010 | 72 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2024 | 835 | 0.220 |
Why?
|
| Chemotaxis | 1 | 2003 | 58 | 0.210 |
Why?
|
| Polymyxin B | 1 | 2024 | 47 | 0.210 |
Why?
|
| Trans-Activators | 2 | 2005 | 799 | 0.210 |
Why?
|
| Thrombosis | 2 | 1998 | 526 | 0.210 |
Why?
|
| Benzimidazoles | 1 | 2004 | 132 | 0.210 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 53 | 0.210 |
Why?
|
| Cations | 1 | 2022 | 39 | 0.200 |
Why?
|
| Female | 17 | 2023 | 66672 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 313 | 0.200 |
Why?
|
| Mice, Knockout | 7 | 2019 | 3742 | 0.200 |
Why?
|
| Uric Acid | 2 | 2003 | 95 | 0.200 |
Why?
|
| Cell Membrane | 4 | 2018 | 462 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 138 | 0.190 |
Why?
|
| Kidney Medulla | 5 | 2003 | 19 | 0.190 |
Why?
|
| Diabetic Nephropathies | 1 | 2022 | 108 | 0.190 |
Why?
|
| Cytokines | 3 | 2015 | 1286 | 0.190 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 2049 | 0.180 |
Why?
|
| RAW 264.7 Cells | 2 | 2018 | 38 | 0.180 |
Why?
|
| Complement C1q | 1 | 2021 | 19 | 0.180 |
Why?
|
| Cyclosporine | 1 | 2001 | 147 | 0.180 |
Why?
|
| Proteinuria | 2 | 2018 | 101 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2022 | 225 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2008 | 89 | 0.180 |
Why?
|
| Loop of Henle | 1 | 2000 | 4 | 0.180 |
Why?
|
| Immunohistochemistry | 6 | 2009 | 1694 | 0.170 |
Why?
|
| Leucine | 1 | 2022 | 310 | 0.170 |
Why?
|
| Betaine | 2 | 1998 | 22 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1399 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2006 | 2594 | 0.170 |
Why?
|
| Extracellular Space | 1 | 2000 | 87 | 0.170 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 40 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2001 | 271 | 0.170 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 22 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 282 | 0.170 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 122 | 0.170 |
Why?
|
| Coumarins | 1 | 2019 | 23 | 0.160 |
Why?
|
| Fever | 2 | 1998 | 297 | 0.160 |
Why?
|
| Retinopathy of Prematurity | 1 | 2019 | 57 | 0.160 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1998 | 6 | 0.160 |
Why?
|
| Diabetes Insipidus | 1 | 1998 | 17 | 0.150 |
Why?
|
| Equipment Reuse | 1 | 1998 | 7 | 0.150 |
Why?
|
| Sp Transcription Factors | 2 | 2009 | 2 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2017 | 1103 | 0.150 |
Why?
|
| Ghrelin | 2 | 2018 | 53 | 0.150 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 3 | 0.150 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2018 | 7 | 0.150 |
Why?
|
| Thermogenesis | 2 | 2018 | 46 | 0.150 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 31 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 282 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 212 | 0.150 |
Why?
|
| Caspases | 4 | 2003 | 162 | 0.150 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2018 | 40 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 1 | 1998 | 84 | 0.150 |
Why?
|
| Hot Temperature | 2 | 1998 | 137 | 0.150 |
Why?
|
| Hyperkalemia | 1 | 2019 | 66 | 0.150 |
Why?
|
| Models, Animal | 2 | 2014 | 465 | 0.140 |
Why?
|
| Carrier Proteins | 5 | 2000 | 1024 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 68 | 0.140 |
Why?
|
| Necrosis | 3 | 2009 | 207 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1999 | 296 | 0.140 |
Why?
|
| Myocardium | 1 | 2003 | 1020 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 650 | 0.140 |
Why?
|
| Free Radical Scavengers | 1 | 1997 | 54 | 0.140 |
Why?
|
| Integrases | 1 | 2018 | 159 | 0.140 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2017 | 2 | 0.140 |
Why?
|
| Metabolomics | 2 | 2018 | 423 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2020 | 444 | 0.140 |
Why?
|
| Quality of Life | 1 | 2007 | 1934 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 359 | 0.140 |
Why?
|
| Adiposity | 1 | 2018 | 190 | 0.140 |
Why?
|
| Osmolar Concentration | 3 | 2004 | 176 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4398 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2019 | 232 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2019 | 254 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 142 | 0.130 |
Why?
|
| Extreme Heat | 1 | 2016 | 1 | 0.130 |
Why?
|
| Heat Stress Disorders | 1 | 2016 | 10 | 0.130 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 136 | 0.130 |
Why?
|
| Myopia | 1 | 2018 | 192 | 0.130 |
Why?
|
| Insulin Resistance | 2 | 2018 | 640 | 0.130 |
Why?
|
| Chemokine CXCL16 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Chemokine CXCL6 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cell Movement | 3 | 2009 | 846 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2019 | 3054 | 0.130 |
Why?
|
| Panniculitis | 1 | 2016 | 19 | 0.130 |
Why?
|
| Epidemics | 1 | 2016 | 54 | 0.120 |
Why?
|
| Climate Change | 1 | 2016 | 43 | 0.120 |
Why?
|
| Osteopontin | 1 | 2015 | 48 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 52 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 35 | 0.120 |
Why?
|
| Gene Expression | 3 | 2001 | 1561 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 1998 | 308 | 0.120 |
Why?
|
| Bleomycin | 1 | 2015 | 153 | 0.120 |
Why?
|
| Albumins | 1 | 2015 | 93 | 0.120 |
Why?
|
| Creatinine | 2 | 2015 | 391 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2018 | 789 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 134 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 145 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2015 | 1633 | 0.120 |
Why?
|
| Calcium Oxalate | 2 | 2005 | 24 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2009 | 1701 | 0.120 |
Why?
|
| Proteins | 2 | 2018 | 1036 | 0.110 |
Why?
|
| Uncoupling Protein 1 | 2 | 2014 | 26 | 0.110 |
Why?
|
| Antibodies | 1 | 2015 | 375 | 0.110 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 61 | 0.110 |
Why?
|
| Risk Factors | 2 | 2023 | 10270 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3416 | 0.110 |
Why?
|
| Base Sequence | 4 | 2000 | 3103 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2019 | 976 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 1998 | 559 | 0.110 |
Why?
|
| Actins | 1 | 2015 | 345 | 0.110 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 399 | 0.110 |
Why?
|
| Shock | 1 | 1994 | 90 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2004 | 17 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2024 | 109 | 0.100 |
Why?
|
| Chemokine CCL2 | 2 | 2003 | 122 | 0.100 |
Why?
|
| ortho-Aminobenzoates | 2 | 2009 | 4 | 0.100 |
Why?
|
| Uncoupling Protein 3 | 1 | 2012 | 7 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2427 | 0.100 |
Why?
|
| Heat-Shock Proteins | 3 | 2001 | 195 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 777 | 0.100 |
Why?
|
| Pneumonia | 1 | 2015 | 323 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2012 | 76 | 0.100 |
Why?
|
| Transfection | 3 | 2014 | 1069 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1696 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 240 | 0.090 |
Why?
|
| Time Factors | 6 | 2014 | 6326 | 0.090 |
Why?
|
| Phenotype | 3 | 2016 | 4259 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1061 | 0.090 |
Why?
|
| Coronary Vessels | 2 | 2008 | 555 | 0.090 |
Why?
|
| Dopamine | 1 | 1993 | 283 | 0.090 |
Why?
|
| Genotype | 2 | 2014 | 2561 | 0.090 |
Why?
|
| Osmotic Pressure | 2 | 2001 | 22 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 1718 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 832 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2905 | 0.090 |
Why?
|
| Autophagy | 1 | 2014 | 393 | 0.090 |
Why?
|
| Liver | 1 | 2017 | 1741 | 0.090 |
Why?
|
| Nephrotic Syndrome | 2 | 2003 | 48 | 0.090 |
Why?
|
| Hemofiltration | 1 | 2010 | 14 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 24 | 0.080 |
Why?
|
| Heart Failure | 1 | 2003 | 2297 | 0.080 |
Why?
|
| Sodium Bicarbonate | 1 | 2010 | 54 | 0.080 |
Why?
|
| NADPH Oxidase 2 | 1 | 2009 | 40 | 0.080 |
Why?
|
| Electron Transport | 1 | 2009 | 55 | 0.080 |
Why?
|
| Adult | 10 | 2021 | 29587 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2000 | 392 | 0.080 |
Why?
|
| Glomerular Basement Membrane | 1 | 2009 | 9 | 0.080 |
Why?
|
| Sodium | 3 | 1998 | 297 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 67 | 0.080 |
Why?
|
| Permeability | 1 | 2009 | 124 | 0.080 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 73 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2010 | 129 | 0.080 |
Why?
|
| Inflammation | 2 | 2022 | 1442 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 129 | 0.080 |
Why?
|
| Middle Aged | 9 | 2020 | 26888 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2000 | 3892 | 0.080 |
Why?
|
| Autoantigens | 1 | 2009 | 118 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 404 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2008 | 50 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 1050 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 368 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 74 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2014 | 700 | 0.070 |
Why?
|
| Culture Media | 2 | 2000 | 182 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 470 | 0.070 |
Why?
|
| Lipolysis | 2 | 2018 | 79 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 683 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2007 | 41 | 0.070 |
Why?
|
| Acute Disease | 1 | 2010 | 1108 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 884 | 0.070 |
Why?
|
| Prognosis | 3 | 2021 | 4624 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2006 | 2 | 0.070 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 2 | 1998 | 9 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 2997 | 0.070 |
Why?
|
| Cell Survival | 2 | 2024 | 812 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 3449 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1239 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2007 | 111 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2003 | 628 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 634 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2009 | 436 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 162 | 0.060 |
Why?
|
| Pyridines | 2 | 2017 | 230 | 0.060 |
Why?
|
| Epithelium | 2 | 1997 | 362 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 173 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 579 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2003 | 231 | 0.060 |
Why?
|
| Aged | 6 | 2020 | 19831 | 0.060 |
Why?
|
| Kidney Concentrating Ability | 1 | 2004 | 16 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2005 | 39 | 0.060 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2005 | 39 | 0.060 |
Why?
|
| Rabbits | 3 | 1996 | 717 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 507 | 0.060 |
Why?
|
| Cell Division | 2 | 2003 | 783 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 526 | 0.060 |
Why?
|
| Smad2 Protein | 1 | 2004 | 49 | 0.060 |
Why?
|
| Insulin | 2 | 2022 | 1204 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 62 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 61 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 664 | 0.060 |
Why?
|
| U937 Cells | 1 | 2003 | 25 | 0.050 |
Why?
|
| Platinum | 1 | 2003 | 12 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 1290 | 0.050 |
Why?
|
| Thrombophlebitis | 1 | 1983 | 22 | 0.050 |
Why?
|
| Calcinosis | 1 | 2005 | 179 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 126 | 0.050 |
Why?
|
| Lidocaine | 1 | 1983 | 46 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 528 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 6145 | 0.050 |
Why?
|
| Nimodipine | 1 | 2003 | 7 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1016 | 0.050 |
Why?
|
| Genes, p53 | 2 | 2001 | 212 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2003 | 48 | 0.050 |
Why?
|
| Child | 1 | 2023 | 24318 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 311 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 357 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 83 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 88 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 173 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 1983 | 218 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1265 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 395 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 241 | 0.050 |
Why?
|
| Biological Transport | 2 | 2001 | 355 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 278 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 471 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 95 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 1892 | 0.050 |
Why?
|
| Heparin | 1 | 1983 | 224 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 243 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 427 | 0.050 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 44 | 0.050 |
Why?
|
| Response Elements | 1 | 2001 | 97 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 691 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 13 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2004 | 590 | 0.040 |
Why?
|
| fas Receptor | 1 | 2000 | 41 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 434 | 0.040 |
Why?
|
| Membranes | 1 | 2000 | 23 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 70 | 0.040 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2000 | 14 | 0.040 |
Why?
|
| Body Water | 1 | 2000 | 90 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 211 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 79 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 1999 | 17 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 508 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 1660 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 43 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 74 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 314 | 0.040 |
Why?
|
| Flavonoids | 1 | 1999 | 78 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 642 | 0.040 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 1998 | 4 | 0.040 |
Why?
|
| Polyuria | 1 | 1998 | 11 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 701 | 0.040 |
Why?
|
| Carbohydrates | 1 | 2018 | 34 | 0.040 |
Why?
|
| Aquaporins | 1 | 1998 | 18 | 0.040 |
Why?
|
| Indium Radioisotopes | 1 | 1998 | 9 | 0.040 |
Why?
|
| Age Factors | 2 | 2016 | 2817 | 0.040 |
Why?
|
| Natriuresis | 1 | 1998 | 37 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 532 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3584 | 0.040 |
Why?
|
| Diuresis | 1 | 1998 | 58 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 723 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 657 | 0.040 |
Why?
|
| Benzazepines | 1 | 1998 | 62 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2018 | 150 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 74 | 0.040 |
Why?
|
| Microvilli | 3 | 1993 | 71 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16284 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2000 | 305 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 76 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 1998 | 119 | 0.040 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1997 | 16 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 209 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 167 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 90 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 1997 | 78 | 0.040 |
Why?
|
| Ocular Hypotension | 1 | 2017 | 4 | 0.040 |
Why?
|
| Vero Cells | 1 | 1997 | 109 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 684 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 2017 | 30 | 0.030 |
Why?
|
| Endocarditis, Bacterial | 1 | 1998 | 134 | 0.030 |
Why?
|
| Drug Overdose | 1 | 1997 | 66 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 78 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 124 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 2017 | 30 | 0.030 |
Why?
|
| Reference Values | 1 | 1998 | 715 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 52 | 0.030 |
Why?
|
| Amides | 1 | 2017 | 89 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Imidazoles | 1 | 1998 | 203 | 0.030 |
Why?
|
| Sri Lanka | 1 | 2016 | 9 | 0.030 |
Why?
|
| Central America | 1 | 2016 | 21 | 0.030 |
Why?
|
| South America | 1 | 2016 | 39 | 0.030 |
Why?
|
| Eating | 1 | 2018 | 367 | 0.030 |
Why?
|
| Dehydration | 1 | 2016 | 39 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2016 | 78 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 490 | 0.030 |
Why?
|
| Phospholipases A2 | 2 | 1993 | 37 | 0.030 |
Why?
|
| Phospholipases A | 2 | 1993 | 39 | 0.030 |
Why?
|
| Graft Survival | 1 | 1998 | 536 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 60 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 31 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 555 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 1017 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 533 | 0.030 |
Why?
|
| India | 1 | 2016 | 214 | 0.030 |
Why?
|
| North America | 1 | 2016 | 240 | 0.030 |
Why?
|
| Cell Plasticity | 1 | 2016 | 32 | 0.030 |
Why?
|
| Medication Errors | 1 | 1997 | 186 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 600 | 0.030 |
Why?
|
| Protein Binding | 1 | 1999 | 1756 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 504 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2058 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2014 | 25 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 504 | 0.030 |
Why?
|
| Osmosis | 1 | 1994 | 16 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2014 | 177 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 293 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2010 | 12374 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2014 | 68 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1034 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2164 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 767 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2008 | 459 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 1993 | 21 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1993 | 28 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1993 | 75 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 1883 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 1997 | 438 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 503 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2019 | 838 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1993 | 247 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1993 | 255 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 1583 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1993 | 128 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 3348 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1996 | 910 | 0.020 |
Why?
|
| Fas Ligand Protein | 2 | 2001 | 33 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3080 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 233 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 65 | 0.020 |
Why?
|
| Hypertension | 2 | 2005 | 1329 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 16 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Nifedipine | 1 | 2008 | 21 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 37 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 357 | 0.020 |
Why?
|
| Sp4 Transcription Factor | 1 | 2007 | 2 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2007 | 7 | 0.020 |
Why?
|
| Sp3 Transcription Factor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 42 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9035 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6583 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 418 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 410 | 0.020 |
Why?
|
| Smad7 Protein | 1 | 2005 | 5 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 618 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3156 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 258 | 0.010 |
Why?
|
| Nafronyl | 1 | 2004 | 1 | 0.010 |
Why?
|
| Absorption | 1 | 2004 | 52 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 198 | 0.010 |
Why?
|
| Oxalates | 1 | 2004 | 32 | 0.010 |
Why?
|
| Doxycycline | 1 | 2005 | 117 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 132 | 0.010 |
Why?
|
| Living Donors | 1 | 2004 | 111 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2005 | 178 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 336 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1983 | 100 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 1331 | 0.010 |
Why?
|
| United States | 1 | 1998 | 10899 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 109 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 204 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 666 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 155 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 2309 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 443 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 941 | 0.010 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2000 | 3 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2000 | 8 | 0.010 |
Why?
|
| Atrophy | 1 | 2001 | 230 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 23 | 0.010 |
Why?
|
| Coenzyme A Ligases | 1 | 2000 | 10 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2000 | 52 | 0.010 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2000 | 19 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1234 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 78 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 436 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 1991 | 40 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1527 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2000 | 75 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2000 | 152 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1369 | 0.010 |
Why?
|
| Clusterin | 1 | 1998 | 11 | 0.010 |
Why?
|
| Aquaporin 6 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 44 | 0.010 |
Why?
|
| Aquaporin 2 | 1 | 1998 | 6 | 0.010 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 7 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 25 | 0.010 |
Why?
|
| Thirst | 1 | 1998 | 5 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 96 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 558 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 382 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1492 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 553 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1997 | 135 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2098 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1193 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1983 | 1046 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 889 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1997 | 852 | 0.010 |
Why?
|
| Sodium Radioisotopes | 1 | 1991 | 1 | 0.010 |
Why?
|
| Melitten | 1 | 1991 | 3 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1991 | 29 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1991 | 179 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 1989 | 35 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1989 | 87 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 19303 | 0.000 |
Why?
|
| Obesity | 1 | 1997 | 2245 | 0.000 |
Why?
|